ACUTAAS vs BETA: Stock Comparison
ACUTAAS CHEMICALS is the larger company by market capitalisation. ACUTAAS CHEMICALS shows a higher ROE, a higher dividend yield and faster revenue growth, while BETA DRUGS shows a lower P/E. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
ACUTAAS leads 10; BETA leads 3 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ACUTAAS | BETA |
|---|---|---|
| Sector | Healthcare | — |
| Industry | Pharmaceuticals | — |
Price
| Metric | ACUTAAS | BETA |
|---|---|---|
| Live Price | ₹3,786.6 | ₹1,805.9 |
| Day Change | 0.42% | -1.89% |
| Volume | 2.74 L | 15,899 |
| 52-Week High | ₹4,045.3 | ₹2,807.9 |
| 52-Week Low | ₹1,570 | ₹990.1 |
| Distance from 52W High | -6.4% | -35.69% |
Valuation
| Metric | ACUTAAS | BETA |
|---|---|---|
| Market Cap | ₹30,997 Cr | ₹2,011 Cr |
| P/E Ratio | 70.58x | 35.56x |
| P/B Ratio | 16.69x | 4.19x |
| EPS | ₹15.29 | ₹18 |
| Book Value | ₹208.96 | ₹220.09 |
| Dividend Yield | 0.07% | 0% |
Growth
| Metric | ACUTAAS | BETA |
|---|---|---|
| Revenue Growth (TTM YoY) | 40.3% | 0% |
| EPS Growth (TTM YoY) | 105.6% | 0% |
| Qtr Sales Growth | 32.53% | 9.51% |
| Qtr Profit Growth | 64.21% | 16.98% |
Profitability & Leverage
| Metric | ACUTAAS | BETA |
|---|---|---|
| ROE | 21.95% | 14.79% |
| ROCE | 23.86% | 18.03% |
| Net Margin | 26.6% | 10.78% |
| Operating Margin | 37.46% | 16.79% |
| Debt to Equity | 0.01x | 0.6x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | ACUTAAS | BETA |
|---|---|---|
| Promoter Holding | 32.66% | 58.91%▼ 0.19 pp |
| FII Holding | 22.62%▲ 1.01 pp | 1.37%▲ 0.35 pp |
| DII Holding | 19.4%▼ 0.16 pp | 6.45%▲ 0.22 pp |
| Public Holding | 25.31%▼ 0.85 pp | 33.27%▼ 0.38 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ACUTAAS CHEMICALS and BETA DRUGS.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.